¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"oxygen therapy"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • adjuvant therapy
    º¸Á¶¿ä¹ý
  • behavioral therapy
    Çൿ¿ä¹ý
  • biologic therapy
    »ý¹°ÇÐÀûÁ¦Á¦¿ä¹ý
  • client-centered therapy
    ³»´ãÀÚÁ߽ɿä¹ý, ÀÇ·ÚÀÎÁ߽ɿä¹ý
  • cognitive therapy
    ÀÎÁö¿ä¹ý
  • cold therapy
    ÇÑ·©¿ä¹ý, Àú¿Â¿ä¹ý
  • combined modality therapy
    º´¿ë¿ä¹ý
  • compression therapy
    ¾Ð¹Ú¿ä¹ý
  • conjoint therapy
    ÇÕµ¿¿ä¹ý
  • consolidation therapy
    °­È­¿ä¹ý
  • corrective therapy
    ±³Á¤¿ä¹ý
  • couples therapy
    ºÎºÎ¿ä¹ý
  • drug therapy
    ¾à¹°¿ä¹ý
  • diathermic therapy
    Åõ°ú¿­¿ä¹ý
  • directive group therapy
    Áö½ÃÁý´Ü¿ä¹ý
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • adjuvant therapy
    º¸Á¶¿ä¹ý
  • microwave therapy apparatus
    ±ØÃÊ´ÜÆÄÄ¡·á±â
  • bacterial interference therapy
    ¼¼±Õ°£¼·¿ä¹ý
  • behavioral therapy
    Çൿ¿ä¹ý
  • biologic therapy
    »ý¹°ÇÐÀûÁ¦Á¦¿ä¹ý
  • boron-neutron capture therapy
    º¸·ÐÁß¼ºÀÚÆ÷ȹ¿ä¹ý
  • client-centered therapy
    ³»´ãÀÚÁ߽ɿä¹ý, ÀÇ·ÚÀÎÁ߽ɿä¹ý
  • cognitive therapy
    ÀÎÁö¿ä¹ý
  • cold therapy
    ÇÑ·©¿ä¹ý
  • combined modality therapy
    º´¿ë¿ä¹ý
  • compression therapy
    ¾Ð¹Ú¿ä¹ý
  • conformal dynamic therapy
    ÀÔüÁ¶Çüµ¿Àû¿ä¹ý
  • conformal radiation therapy
    ÀÔüÁ¶Çü¹æ»ç¼±¿ä¹ý
  • conjoint therapy
    ÇÕµ¿¿ä¹ý
  • consolidation therapy
    °­È­¿ä¹ý
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • gold therapy
    ±Ý Ä¡·á
  • gonadotropin therapy
    ¼º¼±ÀÚ±ØÈ£¸£¸ó¿ä¹ý.
  • grenz-ray therapy
    ±×·£Â꼱ġ·á
  • health resort therapy
    ÀüÁö¿ä¹ý(ÊÙËíËÑ).
  • heparin therapy monitoring
    ÇìÆÄ¸°¿ä¹ý<--Ä¡·á>°¨½Ã
  • hyperbaric oxygenation therapy
    °í¾Ð»ê¼Ò¿ä¹ý(ÍÔäâß«áÈèþÛö)
  • immunization therapy
    ¸é¿ª¿ä¹ý(Øóæ¹èþÛö).
  • immunization therapy
    ¸é¿ª¿ä¹ý(¸é¿ª¿ä¹ý).
  • immunosuppressive therapy
    ¸é¿ª¾ïÁ¦¿ä¹ý(¡­åäð¤èþÛö).
  • immunosuppressive therapy
    ¸é¿ª¾ïÁ¦¿ä¹ý
  • implosive therapy
    ³»ÆÄ Ä¡·á
  • inhalation therapy =i. treatment
    ÈíÀÔ ¿ä¹ý.
  • insulin shock therapy
    Àν¶¸°¼ï¿ä¹ý.
  • insulin therapy
    Àν¶¸°Ä¡·á, Àν¶¸°¿ä¹ý.
  • intensification therapy
    Áõ°­¿ä¹ý.
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • oxygen balance
    »ê¼ÒÆòÇü(¡­øÁû¬).
  • oxygen bath
    »ê¼Ò¿å(ß«áÈé±).
  • oxygen blackout
    »ê¼Ò½Ç½Å(¡­ã÷ãê).
  • oxygen boiling point
    »ê¼ÒºñµîÁ¡(¡­ÝóÔ÷ïÇ).
  • oxygen carbon dioxide diagram
    »ê¼ÒÀÌ»êȭź¼ÒµµÇ¥(ß«áÈì£ß«ûù÷©áÈÓñøú).
  • oxygen carrier
    »ê¼Ò¿î¹Ýü(??ËŅ̃).
  • oxygen carrier
    »ê¼Ò¿î¹Ýü(¡­ê¡Úæô÷).
  • oxygen coefficient
    »ê¼Ò°è¼ö.
  • oxygen collar
    »ê¼Òȯ, »ê¼Ò¼â.
  • oxygen consumption
    »ê¼Ò¼Ò¸ð
  • oxygen consumption
    »ê¼Ò¼Ò¸ð(·®) (¡­á¼ÙÄåÖ).
  • oxygen content
    »ê¼ÒÇÔ(À¯)·®(Ë×ËṴ̂ËôËâ).
  • oxygen content
    »ê¼ÒÇÔ(À¯)·®(ß«áÈùßêóåÖ).
  • oxygen cycle
    »ê¼Òȸ·Î.
  • oxygen cylinder
    »ê¼Ò±âÅë, »ê¼Ò½Ã¸°´õ.
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 4
ROT real oxygen transport; remedial occupational therapy; right occipito-transverse [fetal position]
AART American Association for Rehabilitation Therapy; American Association for Respiratory Therapy
ACT achievement through counseling and treatment; actin; actinomycin; activated clotting time; advanced ...
ERT esophageal radionuclide transit; estrogen replacement therapy; examination room terminal; external r...
ICT icteric, icterus; indirect Coombs test; inflammation of connective tissue; insulin coma therapy; int...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 4
CMRO2 Cerebral metabolic rate for oxygen
CMRO2 Cerebral metabolic rate of oxygen
COD Chemical Oxygen Demand
DO Dissolved Oxygen
EOP Equivalent Oxygen Percentage
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • corrective therapy
    ±³Á¤ ¿ä¹ý
  • cryoprobe therapy
    ³Ãµ¿ Žħ¼ú
  • definitive occlusal therapy
    ÃÖÀûÀÇ ±³ÇÕ Ä¡·á
  • distal point therapy
    ¿øµµ ÃëÇ÷ ¿ä¹ý
  • drug therapy
    ¾à¹° º¹¿ë
  • dual-sex therapy
    ÀÌÁß ¼º ¿ä¹ý
  • duplex therapy
    ÀÌÁß ¿ä¹ý
  • educational therapy
    ÈÆ·Ã ¿ä¹ý
  • electrical stimulation therapy
    Àü±â ÀÚ±Ø ¿ä¹ý
  • electroconvulsive therapy
    Àü±â °æ·Ã ¹æ¹ý, Àü±â °æ·Ã ¿ä¹ý, Àü±â °æ·Ã Ä¡·á
    1. Àü±â ¼ïÀÇ ¹æ¹ý¿¡ ÀÇÇØ¼­ °æ·ÃÀ» À¯¹ßÇÏ´Â Ä¡·á¹ý. 2. Àü·ù¸¦ ³ú¿¡ ÅëÇØ¼­ °æ·ÃÀ» À¯µµÇÏ´Â °Í. ÁÖ·Î Á¤µ¿ Àå¾ÖÀÇ Ä¡·á¿¡ »ç¿ëµÈ´Ù. Çö´ëÀÇ ½ÇÁö ÀÇ·á¿¡¼­´Â ±ÙÀ°ÀÌ¿ÏÁ¦ÀÇ Àû¿ë¿¡ ÀÇÇØ¼­ °æ·Ã Áõ»óÀ» ÃÖ¼ÒÇÑÀ¸·Î °æ°¨½ÃŲ´Ù.
  • electrogalvanic stimulation therapy
    °¥¹Ù´Ð Àü±â ÀÚ±Ø Ä¡·á
  • electron beam therapy
    ÀüÀÚ¼± Ä¡·á
  • endodontic therapy
    ±Ù°ü Ä¡·á
  • exercise therapy
    ¿îµ¿ Ä¡·á
  • extension therapy
    °ßÀÎ ¿ä¹ý
    Áö¼ÓÀûÀ¸·Î °ßÀηÂÀ» ÀÛ¿ë½ÃÄÑ ±ÙÀ°À» Ä¡·áÇÏ´Â ¹ý. ±ÙÀ°Àº Ÿ¹ÚÀ̳ª ¿Ü»ó ¶§ ÀåÃà ¹æÇâÀ¸·Î ´ÜÃàµÇ´Â ÀÏÀÌ ¸¹¾Æ¼­, ¿°ÁÂ, Á»ó, ±×¸®°í ¾î¶² Á¾·ùÀÇ °ñÀý¿¡¼­´Â ÀåÃà ¹æÇâÀ¸·Î Áö¼ÓÀûÀ¸·Î °ßÀÎÇÒ Çʿ䰡 ÀÖ´Ù. °£´ÜÇÑ °ßÀοä¹ýÀ¸·Î´Â ¹Ýâ°íÀÇ ÀÀ¿ëÀÌ ÀÖÀ¸¸ç, ±³Åë»ç°í ¶§ ¸¹ÀÌ ÀϾ´Â °æÃß ¿°Á¿¡´Â ¾Æ·¡ÅÎÀ» °íÁ¤½Ã۰í üÁßÀ» ÀÌ¿ëÇÏ´Â °ßÀαⰡ °í¾ÈµÇ¾î ÀÖ´Ù. ±× ¹Û¿¡ °­¼±À» Ȱ¿ëÇÏ¿© »À¿¡ Á÷Á¢ °ßÀηÂÀ» ¹ÌÄ¡´Â ¹æ¹ýµµ ÀÖ´Ù.
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
adjuvant therapy <oncology, pharmacology> Treatment that is added to increase the effectiveness of a primary treatment. In cancer, adjuvant treatment usually refers to chemotherapy, hormonal therapy or radiation therapy after surgery to increase the likelihood of killing all cancer cells.
(14 May 1997)
alternative therapy A term given to nonconventional therapy usually given by persons who do not have a medical qualification.
(16 Dec 1997)
analytic therapy Short term for psychoanalytic therapy.
(05 Mar 2000)
Antibody Directed Enzyme Prodrug Therapy <pharmacology> A method for targeting a drug to a specific tissue, in which the targeting agent and the drug are administered separately.
The drug is designed to be inactive (a prodrug) until it is converted by an enzyme, which is the targeting agent. The enzyme is coupled to an antibody that directs it to the tissue of interest. When the enzyme arrives at the tissue, the prodrug is activated only at that site, sparing other tissues from potentially toxic side effects.
Acronym: ADEPT
(14 Nov 1997)
anticoagulant therapy The use of anticoagulant drugs to reduce or prevent intravascular or intracardiac clotting.
(05 Mar 2000)
antisense therapy Use of antisense DNA for the inhibition of translation of a specific gene product for therapeutic purposes.
(05 Mar 2000)
art therapy The use of art as an adjunctive therapy in the treatment of neurological, mental, or behavioural disorders.
(12 Dec 1998)
autoserum therapy Therapy with serum obtained from the patient's own blood.
(05 Mar 2000)
aversion therapy <psychology> A form of behaviour therapy that pairs an unpleasant stimulus with undesirable behaviour(s) so that the patient learns to avoid the latter.
See: aversive training.
(05 Mar 2000)
aversive therapy <psychology> A treatment that suppresses undesirable behaviour by simultaneously exposing the subject to unpleasant consequences.
(12 Dec 1998)
behaviour therapy The application of modern theories of learning and conditioning in the treatment of behaviour disorders.
(12 Dec 1998)
biological therapy <oncology> Treatment with substances that can stimulate the immune system to fight disease more effectively.
Synonym: immunotherapy.
(16 Dec 1997)
boron neutron capture therapy A technique for the treatment of neoplasms, especially gliomas and melanomas in which boron-10, an isotope, is introduced into the target cells followed by irradiation with thermal neutrons.
(12 Dec 1998)
radiation therapy <radiobiology> Treatment with high energy radiation from X-rays or other sources of radiation.
(16 Dec 1997)
radium beam therapy Therapeutic use of radium rays, the source of which is a quantity of radium at a distance from the patient.
Synonym: radium beam therapy.
(05 Mar 2000)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 4
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 4
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 4
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 4
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 4
ÅëÇÕ°Ë»ö ¿Ï·á